Drug Discovery World

JULY 11, 2023

Drug discovery and development timelines can span 10-15 years or more from initial discovery to market approval and typically require the analysis of massive amounts of data. Biomarker discovery is becoming a vibrant area for exploiting the power of AI and ML.

Big Data 40

Big Data Development Life Science Drugs 40

Drug Discovery World

FEBRUARY 6, 2024

Sanofi has stated that it intends to become the first pharma company “powered by AI at scale”, and as part of this ambition, agreed a collaboration with BioMap to co-develop advanced AI models and protein Large Language Models that that it hopes will enable biologics design and multiparametric optimisation 2.

Marketing 69

Marketing Medicine Genome Genomics 69

Drug Discovery World

JULY 17, 2024

Most NDDs are thought to be genetic and caused by changes to DNA, however, to date, around 60% of individuals with these conditions do not know the specific DNA change that causes their disorder. This discovery was initially made using data from the 100,000 Genomes Project, a study led by Genomics England and NHS England.

Genetics 52

Genetics Genome Project Genome Genomics 52

Drug Discovery World

MAY 4, 2023

The drug target for Penicillin is a protein that helps bacteria to synthesise its cell wall. One of the first and most basic requirements for a protein to be characterised as a drug target is to show that inhibiting its function prevents the disease. Big data handling and machine learning made progress by leaps.

Medicine 52

Medicine Protein Drugs Bioassay 52

Drug Discovery World

SEPTEMBER 6, 2022

The use of big data and AL to direct the best patient candidates for CGT and to provide the best understanding of efficacy and benefits.” – ? Research into genomic medicines is only at its infancy. Chris Nowers, CEO, ONK Therapeutics. . “

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52